Medco Settlement Will Influence Medicare Part D Regs, Consultant Says
Executive Summary
The regulations to implement the Medicare Part D prescription drug benefit will be influenced by the recent Medco settlement with federal and state prosecutors, Health Strategies Consultancy President Dan Mendelson told the Pharmaceutical Care Management Association's legislative conference May 5 in Washington, D.C
You may also be interested in...
Drug Card Price Complexity Is CMS Learning Experience, Consultant Says
The Centers for Medicare & Medicaid Services' experience dealing with the complexity of prescription drug pricing through the Medicare discount card program is a valuable learning experience as the agency works on regulations for the Part D benefit, Health Strategies Consultancy President Dan Mendelson said
PBM “Transparency” Defined In Medco Settlement
The Medco injunction requires the pharmacy benefit management company to disclose the existence of rebate relationships in its communications to clients, physicians and patients
Medco Settlement Sets “Gold Standard” For PBMs Ahead Of Medicare Rx
Prosecutors expect that other pharmacy benefit management companies will adopt codes of conduct based on Medco's April 26 settlement with 20 state attorneys general and the U.S. Attorney in Philadelphia